These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2069894)

  • 21. Images in clinical medicine. Vitiligo and cutaneous melanoma.
    Redondo P; Del Olmo J
    N Engl J Med; 2008 Jul; 359(3):e3. PubMed ID: 18635425
    [No Abstract]   [Full Text] [Related]  

  • 22. Vitiligo and cutaneous melanoma. A case study.
    Schallreuter KU; Levenig C; Berger J
    Dermatologica; 1991; 183(4):239-45. PubMed ID: 1809584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Adhesive tape induced depigmentation. An ultrastructural study and comparison with vitiligo and vitiliginous depigmentation associated with melanoma (author's transl)].
    Frenk E; Kocsis M
    Dermatologica; 1974; 148(5):276-84. PubMed ID: 4420330
    [No Abstract]   [Full Text] [Related]  

  • 24. Vitiligo and malignant melanoma.
    Fodor J; Bodrogi I
    Neoplasma; 1975; 22(4):445-8. PubMed ID: 1196428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitiligo associated with metastatic malignant melanoma.
    Cavallari V; Cannavò SP; Ussia AF; Moretti G; Albanese A
    Int J Dermatol; 1996 Oct; 35(10):738-40. PubMed ID: 8891830
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical and statistical study of 100 patients with vitiligo. II. Associated lesions].
    Ortonne JP; Perrot H; Thivolet J
    Sem Hop; 1976 Mar; 52(11):679-86. PubMed ID: 188147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hypomelanosis of the skin and malignant melanoma (author's transl)].
    Ortonne JP; Gauthier Y; Guillet G; Gauthier O
    Ann Dermatol Venereol; 1978 Dec; 105(12):1043-52. PubMed ID: 753117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basal cell carcinoma arising in a patient with vitiligo.
    Arnon O; Mamelak AJ; Goldberg LH
    J Drugs Dermatol; 2008 Nov; 7(11):1075-6. PubMed ID: 19110741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of internal malignancies, cutaneous malignant melanoma and non-melanoma skin cancer among patients with vitiligo: a systematic review and meta-analysis.
    Long VS; Law YXT; Yew YW; Choi CE
    J Eur Acad Dermatol Venereol; 2022 Oct; 36(10):e829-e831. PubMed ID: 35686630
    [No Abstract]   [Full Text] [Related]  

  • 30. Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study.
    Quaglino P; Marenco F; Osella-Abate S; Cappello N; Ortoncelli M; Salomone B; Fierro MT; Savoia P; Bernengo MG
    Ann Oncol; 2010 Feb; 21(2):409-414. PubMed ID: 19622589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IX. Malignant melanoma and vitiligo.
    J Invest Dermatol; 1979 Nov; 73(5 Pt 2):491-4. PubMed ID: 501142
    [No Abstract]   [Full Text] [Related]  

  • 32. Favorable prognosis for malignant melanomas associated with acquired melanocytic nevi.
    Friedman RJ; Rigel DS; Kopf AW; Lieblich L; Lew R; Harris MN; Roses DF; Gumport SL; Ragaz A; Waldo E; Levine J; Levenstein M; Koenig R; Bart RS; Trau H
    Arch Dermatol; 1983 Jun; 119(6):455-62. PubMed ID: 6859885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metastatic malignant melanoma associated with vitiligo-like depigmentation.
    Wang JR; Yu KJ; Juan WH; Yang CH
    Clin Exp Dermatol; 2009 Mar; 34(2):209-11. PubMed ID: 18691245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regressing cutaneous malignant melanoma and vitiligo-like depigmentation.
    Arpaia N; Cassano N; Vena GA
    Int J Dermatol; 2006 Aug; 45(8):952-6. PubMed ID: 16911383
    [No Abstract]   [Full Text] [Related]  

  • 35. Vitiligo in patients with metastatic melanoma: a good prognostic sign.
    Nordlund JJ; Kirkwood JM; Forget BM; Milton G; Albert DM; Lerner AB
    J Am Acad Dermatol; 1983 Nov; 9(5):689-96. PubMed ID: 6643767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The complex relationships between sentinel node positivity, patient age, and primary tumor desmoplasia: analysis of 2303 melanoma patients treated at a single center.
    Sassen S; Shaw HM; Colman MH; Scolyer RA; Thompson JF
    Ann Surg Oncol; 2008 Feb; 15(2):630-7. PubMed ID: 18080717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the association between vitiligo and malignant melanoma.
    Lindelöf B; Hedblad MA; Sigurgeirsson B
    Acta Derm Venereol; 1998 Nov; 78(6):483-4. PubMed ID: 9833063
    [No Abstract]   [Full Text] [Related]  

  • 38. Malignant melanoma and vitiligo.
    Milton GW; McCarthy WH; Carlon A
    Australas J Dermatol; 1971 Dec; 12(3):131-42. PubMed ID: 5146927
    [No Abstract]   [Full Text] [Related]  

  • 39. Malignant melanoma and vitiligo-like leukoderma: an electron microscopic study.
    Koh HK; Sober AJ; Nakagawa H; Albert DM; Mihm MC; Fitzpatrick TB
    J Am Acad Dermatol; 1983 Nov; 9(5):696-708. PubMed ID: 6643768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitiliginous achromia with malignant melanoma. Tyrosinase activity and ultrastructural study of achromic and normal skin.
    Perrot H; Ortonne JP; Schmitt D
    Arch Dermatol Res (1975); 1977 Jan; 257(3):247-53. PubMed ID: 402121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.